Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study. - Hughes, Derralynn A.; Nicholls, Kathleen; Sunder‐Plassmann, Gere; Jovanovic, Ana; Feldt‐Rasmussen, Ulla; Schiffmann, Raphael; Giugliani, Robert; Jain, Vipul; Viereck, Chris; Castelli, Jeffrey P.; Skuban, Nina; Barth, Jay A.; et al. (American Journal of Medical Genetics. Part A, 2019)